The ACR recently issued the first formal international consensus guidance statement on diagnosing and managing VEXAS syndrome.
Collaborative research by the University of Tokyo and RIKEN Center for Biosystems Dynamics Research has led to the ...
In this interview, Dr. Eleonora Juarez explains how Oxford Nanopore’s new Hereditary Cancer Panel could streamline testing, ...
Oliver Bathe walks through addressing the surge in papillary thyroid cancer incidence by refining cancer care through ...
The most basic assumption about how psychedelic medicine works is at least partially flawed: Psychedelics are altering not ...
In one of the first demonstrations of the impact of last year’s Loper Supreme Court decision on challenges to agency ...
A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found ...
A South Korean research group has reported in a new paper that artificial intelligence and light-based genetic tools can work together to diagnose and stop Parkinson’s-like disease in mice. The work ...
Lewy body dementia affects more than one million people in the United States. It has two forms: Dementia with Lewy bodies and ...
The investment from Brown parents Giammaria and Sabrina Giuliani will support scholars seeking to unlock the potential of RNA ...
News-Medical.Net on MSN
AI tool accurately distinguishes between glioblastoma and primary central nervous system lymphoma
A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback